Pregabalin In Partial Seizures (PREPS): An Open-Label, Multicenter Add On Therapy Trial

Mise à jour : Il y a 4 ans
Référence : NCT00407797

Femme et Homme

  • | Pays :
  • Mexico
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The purpose of this study is to assess the clinical improvement by partial seizures reduction, safety and tolerability of subjects having partial epilepsy related to the adjunction of pregabalin BID (75 to 300mg day titration, BID) to existing standard AED (Antiepileptic drugs).


Critère d'inclusion

  • Partial seizures

Liens